Lifting the Veil in the European Medicines Agency
August 28, 2014
I wrote a number of blogs on the apparent change of policy on transparency by the European Medicines Agency when it published a new draft policy for targeted consultation last May – see here, here, and here for example. The Management Board of the agency were due to decide on this changes in June but… » read more
consumers, Ethics in Business, EU institutions, EU Priorities 2020, health, Health & Consumers, Innovation and Growth, medicines, pharmaceuticals, Public Affairs, Science & Research, Trade & Industry |